Fatty Acid Supplementation Reverses the Small Colony Variant Phenotype in Triclosan-Adapted Staphylococcus aureus: Genetic, Proteomic and Phenotypic Analyses

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Bazaid, Abdulrahman S ^a,b   Forbes, Sarah ^c   Humphreys, Gavin J ^a   Ledder, Ruth G ^a   O'Cualain, Ronan ^a   McBain, Andrew J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF HAIL   (Saudi Arabia)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FATTY ACID; TOPICAL ANTIINFECTIVE AGENT; TRICLOSAN; VIRULENCE FACTOR;

DIETARY SUPPLEMENT; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHENOTYPE; PROCEDURES; PROTEOMICS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VIRULENCE; WHOLE GENOME SEQUENCING;

ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL PROTEINS; DIETARY SUPPLEMENTS; FATTY ACIDS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PROTEOMICS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRICLOSAN; VIRULENCE; VIRULENCE FACTORS; WHOLE GENOME SEQUENCING;

EID: 85042875964     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-21925-6     Document Type: Article

References (31)

1. Chambers, H. F. & DeLeo, F. R. Waves of Resistance: Staphylococcus aureus in the Antibiotic Era. Nat Rev Microbiol 7, 629-641 (2009)
2. Kluytmans, J., van Belkum, A. & Verbrugh, H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10, 505-20 (1997)
3. Kahl, B. C. Small colony variants (SCVs) of Staphylococcus aureus - A bacterial survival strategy. Infect Genet Evol 21, 515-522 (2014)
4. Kahl, B. et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177, 1023-9 (1998)
5. vonEiff, C. et al. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 179, 4706-4712 (1997)
6. Tuchscherr, L. et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. Embo Mol Med 3, 129-141 (2011)
7. Proctor, R. A. et al. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Fronti Cell Infect Microbiol 4 (2014)
8. Kriegeskorte, A. et al. Inactivation of thyA in Staphylococcus aureus Attenuates Virulence and Has a Strong Impact on Metabolism and Virulence Gene Expression. Mbio 5 (2014)
9. Proctor, R. A. et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4, 295-305 (2006)
10. Bayston, R., Ashraf, W. & Smith, T. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics. J Antimicrob Chemother 59 (2007)
11. Latimer, J., Forbes, S. & McBain, A. J. Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan. Antimicrob Agents Chemother 56 (2012)
12. McMurry, L. M., Oethinger, M. & Levy, S. B. Triclosan targets lipid synthesis. Nature 394 (1998)
13. Escalada, M. G., Russell, A. D., Maillard, J. Y. & Ochs, D. Triclosan-bacteria interactions: single or multiple target sites? Lett Appl Microbiol 41, 476-481 (2005)
14. Villalain, J., Mateo, C. R., Aranda, F. J., Shapiro, S. & Micol, V. Membranotropic effects of the antibacterial agent Triclosan. Arch Biochem Biophys 390, 128-36 (2001)
15. Forbes, S., Latimer, J., Bazaid, A. & McBain, A. J. Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus. Antimicrob Agents Chemother 59, 4809-4816 (2015)
16. Kahl, B. C. Small colony variants (SCVs) of Staphylococcus aureus - A bacterial survival strategy. Infect Genet Evol 21, 515-522 (2014)
17. Xu, H. et al. Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus. Biochemistry 47, 4228-4236 (2008)
18. Ciusa, M. L. et al. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. Int J Antimicrob Agents 40 (2012)
19. Brinster, S. et al. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458, 83-6 (2009)
20. Balwit, J. M., Vanlangevelde, P., Vann, J. M. & Proctor, R. A. Gentamicin-Resistant Menadione and Hemin Auxotrophic Staphylococcus-Aureus Persist within Cultured Endothelial-Cells. J Infect Dis 170, 1033-1037 (1994)
21. Purves, J., Cockayne, A., Moody, P. C. E. & Morrissey, J. A. Comparison of the Regulation, Metabolic Functions, and Roles in Virulence of the Glyceraldehyde-3-Phosphate Dehydrogenase Homologues gapA and gapB in Staphylococcus aureus. Infect Immun 78, 5223-5232 (2010)
22. Ramarao, N., Nielsen-Leroux, C. & Lereclus, D. The Insect Galleria mellonella as a Powerful Infection Model to Investigate Bacterial Pathogenesis. Jove-J Vis Exp (2012)
23. Nielsen, L. N. et al. Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiency. BMC Microbiol 13, 177 (2013)
24. Josse, J., Laurent, F. & Diot, A. Staphylococcal Adhesion and Host Cell Invasion: Fibronectin-Binding and Other Mechanisms. Front Microbiol. 8, 2433 (2017)
25. Mainiero, M. et al. Differential Target Gene Activation by the Staphylococcus aureus Two-Component System saeRS. J Bacteriol 192, 613-623 (2010)
26. Kuroda, H., Kuroda, M., Cui, L. & Hiramatsu, K. Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. Fems Microbiol Lett 268, 98-105 (2007)
27. Senn, M. M., Bischoff, M., von Eiff, C. & Berger-Bachi, B. SigmaB activity in a Staphylococcus aureus hemB mutant. J Bacteriol 187, 7397-406 (2005)
28. Morvan, C. et al. Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials. Nat Commun 7, 12944 (2016)
29. Moore, L. E., Ledder, R. G., Gilbert, P. & McBain, A. J. In vitro study of the effect of cationic biocides on bacterial population dynamics and susceptibility. Appl Environ Microbiol 74, 4825-34 (2008)
30. Mempel, M. et al. Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol 146, 943-51 (2002)
31. Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat Methods 6, 359-62 (2009).